Veeral Desai, Chief Strategy & Development Officer at agilon health, inc. (AGL), sold 185,925 shares at $20.00 ($3.8M) on 2022-04-22, disclosed to the SEC on 2022-04-25.
Open-market sale of $3.8M AGL by Chief Strategy & Development Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $20.43 | 69,824 | $1.4M | 37.5% |
| 2 | $20.43 | 69,824 | $1.4M | 37.5% |
| 3 | $21.35 | 9,744 | $208K | 5.5% |
| 4 | $21.35 | 9,744 | $208K | 5.5% |
| 5 | $20.00 | 26,789 | $536K | 14.1% |
| Total | $20.46 avg | 185,925 |
| $3.8M |
| 100% |
| Filing → |
| AGL | SELL | 2023-03-27 | $4.1M | — | Filing → |
| AGL | SELL | 2023-03-17 | $1.6M | — | Filing → |
| AGL | SELL | 2022-07-25 | $2.2M | — | Filing → |